Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis?
- PMID: 17934295
- DOI: 10.1159/000109223
Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis?
Abstract
Objective: To assess the complications of third-trimester amniocentesis for fetal karyotyping in women unwilling to accept the fetal loss risks of second-trimester amniocentesis.
Methods: Retrospective study of singleton pregnancies that underwent a third-trimester amniocentesis for karyotyping. 150 complete charts between 1998 and 2005 were reviewed.
Results: The indications were: isolated abnormal second-trimester biochemical markers (n = 57), isolated maternal age >38 years (n = 46), integrated risk (maternal age, first-trimester nuchal translucency, second-trimester maternal serum markers) >1/250 (n = 22), history of chromosomal abnormality (n = 17) or maternal choice (n = 8). The median maternal age and gestational age at sampling were: 40 years (23-48), 32.4 weeks (29.7-37.1). Median interval between amniocentesis, definitive result of amniocentesis, and delivery were 14 days (7-42), and 49 days (10-67) respectively. There were no abnormal karyotypes and no termination of pregnancy. Six women out of 150 (4%) had spontaneous labor before 36 weeks (2% after 36 weeks).
Conclusion: The risk of spontaneous labor before 37 weeks after late amniocentesis is 4% (2% before 36 weeks). This technique provides a late but safe reassurance to women who are unwilling to accept the risks of earlier fetal karyotyping. This is of interest to countries such as France where legislation permits late termination of pregnancy.
(c) 2007 S. Karger AG, Basel
Similar articles
-
[Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss].J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):385-91. doi: 10.1016/j.jgyn.2007.11.030. Epub 2008 Jan 8. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18191913 French.
-
Fetal loss rate after second trimester amniocentesis at different gestational age.Acta Obstet Gynecol Scand. 1999 Jan;78(1):10-4. Acta Obstet Gynecol Scand. 1999. PMID: 9926885
-
Amniocentesis in the third trimester of pregnancy.Prenat Diagn. 2007 Nov;27(11):1000-4. doi: 10.1002/pd.1820. Prenat Diagn. 2007. PMID: 17636852
-
Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.Obstet Gynecol. 1995 Jun;85(6):952-6. doi: 10.1016/0029-7844(95)00077-5. Obstet Gynecol. 1995. PMID: 7539525 Review.
-
Placental biopsy.Br J Hosp Med. 1989 Apr;41(4):334, 338-44, 348. Br J Hosp Med. 1989. PMID: 2655798 Review.
Cited by
-
Amniocentesis in pregnancies at or beyond 24 weeks: an international multicenter study.Am J Obstet Gynecol. 2025 Apr;232(4):402.e1-402.e16. doi: 10.1016/j.ajog.2024.06.025. Epub 2024 Jun 22. Am J Obstet Gynecol. 2025. PMID: 38914189 Free PMC article.
-
NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability.J Genet Couns. 2014 Feb;23(1):72-8. doi: 10.1007/s10897-013-9609-z. Epub 2013 May 31. J Genet Couns. 2014. PMID: 23723049
-
Late amniocentesis: better late than never? A single referral centre experience.Arch Gynecol Obstet. 2023 Aug;308(2):463-470. doi: 10.1007/s00404-022-06662-6. Epub 2022 Aug 8. Arch Gynecol Obstet. 2023. PMID: 35939110
MeSH terms
LinkOut - more resources
Full Text Sources